Skip to main content

Table 2 In vitro antifungal susceptibility profile of various Candida species

From: Antifungal susceptibility and phenotypic virulence markers of Candida species isolated from Nepal

CLSI breakpoints (μg/ml) Amphotericin B Caspofungin Fluconazole Voriconazole
S I R S I R S I R S I R
≤ 4 8–16 ≥ 32 ≤ 0.25 0.5 ≥ 1 ≤ 2 4 ≥ 8 ≤ 0.12 0.25–0.5 ≥ 1
C. albicans, n = 48 (%) 47 (97.9) 0 (0) 1 (2.1) 41 (85.4) 4 (8.3) 3 (6.3) 11 (23) 14 (29) 23 (48) 37 (77) 11 (23) 0 (0)
C. tropicalis, n = 11 (%) 0 (0) 11 (100) 0 (0) 11 (100) 0 0 0 0 4 (36.4) 1 (9) 6 (54.6) 0 0 9 (81.8) 0 (18.2)
C. glabrata, n = 9 (%) 0 (0) 9 (100) 0 (0) 9 (100) 0 0 0 0 6 (66.7) 1 (11.1) 2 (22.2) 0 0 8 (88.9) 1 (11.1)
C. krusei, n = 3 (%) 0 0 2 (66.7) 1 (33.3) 2 (66.7) 1 (33.3) 0 (0) 1 (33.3) 0 (0) 2 (66.7) 0 0 2 (66.7) 1 (33.3)